Minimum important difference for validated instruments in women with urge incontinence
- PMID: 21563210
- PMCID: PMC5373473
- DOI: 10.1002/nau.21028
Minimum important difference for validated instruments in women with urge incontinence
Abstract
Aims: Minimum important difference (MID) estimates the minimum degree of change in an instrument's score that correlates with subjective sense of improvement. The aim of this study was to estimate the MID for the Urogenital Distress Inventory (UDI), Incontinence Impact Questionnaire (IIQ) and Overactive Bladder Questionnaire (OAB-q) using anchor and distribution-based approaches in patients with urge-predominant incontinence and whether MID changes over time.
Methods: This was a sub-analysis of a multi-center trial of 307 women with pure urge (11) or urge-predominant (296) incontinence who completed condition-specific instruments 10 weeks and 8 months after randomization to anticholinergic medication with or without behavioral therapy. We applied anchor-based methods only when the Kendall's rank correlations between the anchors (Global Perception of Improvement (GPI), Patient Satisfaction Questionnaire (PSQ), and incontinence episodes) and the incontinence instruments (UDI, UDI irritative subscale, IIQ, and OAB-q subscales) were ≥ 0.3. We applied three distribution-based methods to all instruments: effect sizes of ± 0.2 SD (small) and ± 0.5 SD (medium), and standard error of measurement of ± 1. Analyses were performed at both time points.
Results: Anchor-based MIDs for the UDI ranged from -35 to -45 and -15 to -25 for the irritative subscale distribution-based methods MIDs for UDI and IIQ ranged between -10 to -25 and -19 to -49, respectively, reflective of a reduction in bother and symptom severity (SS). OAB-q subscale MIDs ranged from +5 to +12, denoting improved quality of life (HRQL) and -13 to -25, consistent with a reduction in SS.
Conclusions: The MID in women with urge-predominant UI for the UDI and UDI irritative are -35 and -15. Our findings are consistent with previously reported MIDs for the OAB-q subscales. Distribution-based method MIDs are lower values than anchor-based values. The MID did not typically change over the time.
Trial registration: ClinicalTrials.gov NCT00090584.
Copyright © 2011 Wiley-Liss, Inc.
References
-
- Hartmann KE, McPheeters ML, Biller DH, et al. Evidence report/technology assessment no 187. Rockville, MD: Agency for Healthcare Research and Quality. AHRQ publication no 09-E017; 2009. [4 Dec 2009]. Treatment of overactive bladder in women. Accessed at http://www.ahrq.gov/downloads/pub/evidence/pdf/bladder/bladder.pdf.
-
- Irwin DE, Milsom I, Kopp Z, Abrams P. Symptom bother and health care-seeking behavior among individuals with overactive bladder. Eur Urol. 2008;53(5):1029–37. - PubMed
-
- Hu TW, Wagner TH, Bentkover JD, Leblanc K, Zhou SZ, Hunt T. Costs of urinary incontinence and overactive bladder in the United States: a comparative study. Urology. 2004;63(3):461–465. - PubMed
-
- Coyne KS, Zhou Z, Thompson C, Versi E. The impact on health-related quality of life of stress, urge and mixed urinary incontinence. BJU Int. 2003;92:731–5. - PubMed
-
- Shumaker SA, Wyman JF, Uebersax J, McClish DK, Fantl JA. Health-related quality of life measures for women with urinary incontinence: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Qual Life Res. 1994;3:291–306. - PubMed
Publication types
MeSH terms
Substances
Associated data
Grants and funding
- U01 DK60393/DK/NIDDK NIH HHS/United States
- U01 DK058234/DK/NIDDK NIH HHS/United States
- U01 DK58234/DK/NIDDK NIH HHS/United States
- U01 DK060393/DK/NIDDK NIH HHS/United States
- U01 DK60379/DK/NIDDK NIH HHS/United States
- U01 DK060380/DK/NIDDK NIH HHS/United States
- U01 DK060397/DK/NIDDK NIH HHS/United States
- U01 DK60380/DK/NIDDK NIH HHS/United States
- U01 DK60395/DK/NIDDK NIH HHS/United States
- U01 DK060401/DK/NIDDK NIH HHS/United States
- U01 DK060395/DK/NIDDK NIH HHS/United States
- U01 DK58229/DK/NIDDK NIH HHS/United States
- U01 DK60397/DK/NIDDK NIH HHS/United States
- U01 DK58231/DK/NIDDK NIH HHS/United States
- U01 DK060379/DK/NIDDK NIH HHS/United States
- U01 DK60401/DK/NIDDK NIH HHS/United States
- U01 DK058229/DK/NIDDK NIH HHS/United States
- U01 DK58225/DK/NIDDK NIH HHS/United States
- U01 DK058225/DK/NIDDK NIH HHS/United States
- U01 DK058231/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
